No Data
Express News | Zymeworks Shares up 2.5% Premarket After FDA Approves Co, Jazz Pharma's Biliary Tract Cancer Drug
Express News | Zymeworks Inc - to Receive $25M Milestone Payment From Jazz Pharmaceuticals
Jazz Pharmaceuticals Receives US FDA Accelerated Approval for Biliary Tract Cancer Treatment
Express News | Jazz Pharmaceuticals PLC : Piper Sandler Cuts Target Price to $163 From $166
Express News | Jazz Pharmaceuticals PLC - Phase 3 Trial Herizon-BTC-302 Ongoing for Zanidatamab
Express News | Jazz Pharmaceuticals PLC - Serious Adverse Reactions in 53% of Patients Receiving Ziihera
No Data
No Data